Monday, October 26, 2026 · Daily editionET --:--:--

By invitation only

Impact of Robotic Glove Use on Quality of Life, Grip Strength and Fine Motor Control in ALS

NCT07298486 · Nova Southeastern University · Updated 25 Feb 2026

What is being tested
Robotic Glove Use
For
Amyotrophic Lateral Sclerosis (ALS)
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years to 99 years. About 5 people. The full rules are on the registry page.
Where
United States
When
Starts or started 9 Feb 2026, ends 30 July 2026. Registered 23 Dec 2025.
Results
None posted yet.

In the researchers' words

The goal of this clinical trial is to determine the impact of robotic glove use on quality of life, grip strength and fine motor control in participants with Amyotrophic Lateral Sclerosis (ALS). This will provide valuable insights into how an assistive technology intervention can influence functional ability in daily tasks and enhance overall well-being in individuals impacted by ALS. Participants will attend 3 in-person clinic visits (BASE, 4 week and 8 week visit) and 2 Telehealth visits (occurring 24 hours after BASE and 4 week visit). The in-person clinic visits will include assessments by either a physical or occupational therapist, followed by assessments and scoring of grip strength, various fine motor strength assessments of affected hand, fine motor coordination assessment of the affected hand and various quality of life scales. The participant will be fitted and measured for the appropriately sized robotic glove. Once the fit is confirmed, both the participant and caregiver will receive education on how to don and doff the glove, power it on and off, and follow the study protocol. Once they demonstrate understanding and independence with these steps, the intervention will begin. The robotic glove intervention consists of either the participant or caregiver donning the glove and powering it on. A timer will be set for 20 minutes. The participant will sit…
ClinicalTrials.gov, NCT07298486

Sites

  • Nova Southeastern University, David and Cathy Husman Neuroscience InstituteDavie, Florida, United States